Diabetes – Nyligen publicerad artikel 14 maj 2019 Nyhet Cost-effectiveness of once-weekly semaglutide versus dulaglutide and lixisenatide in patients with type 2 diabetes with inadequate glycemic control in Sweden Läs mer